logo-loader
viewOncoSenX

OncoSenX targeting solid tumors with its unique technology

OncoSenX Inc CEO Matthew Scholz sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The late stage pre-clinical cancer company, based in Seattle, Washington, targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks slow down but show no signs of giving up last...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, eased 0.9% higher at 125.2 points. Elsewhere, the OTCQX Cannabis index fell 1% to 504.6 points. Buds today are TILT Holdings Inc (CSE:TILT) (OTCMKTS:TLLTF), Aphria Inc (TSE:APHA)...

15 hours, 53 minutes ago

2 min read